Report copyright - Novel therapeutical approach based on gene-therapy · Genomic locus Target sequence sgRNA Cas9 PAM Cleavage site 5’ 3’ 5’ 3’ 5’ 3’ CRISPR/Cas9 type II is an endonuclease
Please pass captcha verification before submit form
Please pass captcha verification before submit form